During the past decade, Shenzhen Children's Hospital conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 3 clinical trials were completed, i.e. on average, 10.7% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 3 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shenzhen Children's Hospital" #1 sponsor was "Shenzhen Geno-Immune Medical Institute" with 9 trials, followed by "Takeda" with 5 trials sponsored, "Jiaxiang Chen" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Ark Biosciences Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shenzhen Children's Hospital" #1 collaborator was "Shenzhen Children's Hospital" with 12 trials as a collaborator, "The Seventh Affiliated Hospital of Sun Yat-sen University" with 5 trials as a collaborator, "Shenzhen Hospital of Southern Medical University" with 4 trials as a collaborator, "Anhui Provincial Children's Hospital" with 1 trials as a collaborator and "Beijing Children's Hospital" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Shenzhen Children's Hospital" are "Dravet Syndrome (DS)" (3 trials), "Epilepsy" (3 trials), "Anesthesia" (2 trials), "Lennox Gastaut Syndrome (LGS)" (2 trials) and "Surgery" (2 trials). Many other conditions were trialed in "Shenzhen Children's Hospital" in a lesser frequency.

Most popular intervention types in "Shenzhen Children's Hospital" are "Biological" (12 trials), "Drug" (12 trials), "Device" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Soticlestat" (4 trials), "4SCAR-276" (1 trials), "4SCAR-PSMA T cells" (1 trials) and "4SCAR19 and 4SCAR20/22/70/PSMA/13/79b/GD2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shenzhen Children's Hospital" are 26 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Shenzhen Children's Hospital". undefined are not yet recruiting, 14 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Shenzhen Children's Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Shenzhen Children's Hospital, 10 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".